Peer-reviewedCC BYFrontiers in medicine
Early clinical outcomes after switching to faricimab in previously treated diabetic macular edema
- 1Department of Ophthalmology, People's Hospital of Leshan , , ,
Related
- Switching to Faricimab in Patients with Chronic Diabetic Macular Edema Refractory to Previous Anti-VEGF Therapy: Morphological and Functional Outcomes Including Optical Coherence Tomography Angiography Parameters
- Use of faricimab for refractory diabetic macular edema in real-world clinical practice: When anatomical success meets functional limits
- Effectiveness and Treatment Burden of Faricimab in Neovascular AMD: A Real-World Analysis of Treatment-Naïve and Previously Treated Patients in Poland
- Successful management of high-risk proliferative diabetic retinopathy during pregnancy with intravitreal faricimab
- Temporal patterns of tuberculosis-associated hyperglycaemia and its effect on treatment outcomes in individuals not previously diabetic: A prospective cohort study
BibTeX
@article{chen2026early,
title = {{Early clinical outcomes after switching to faricimab in previously treated diabetic macular edema}},
author = {Jing Chen and Bin Chen},
journal = {Frontiers in medicine},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13661413},
note = {CC BY},
}
RIS
TY - JOUR
TI - Early clinical outcomes after switching to faricimab in previously treated diabetic macular edema
AU - Jing Chen
AU - Bin Chen
PY - 2026
DA - 2026/10/16
JO - Frontiers in medicine
UR - https://europepmc.org/article/PMC/PMC13661413
SN - 2296-858X
ER -